Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cortet

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Endocrinology|September 1, 1999
Type 1 multiple endocrine neoplasia (MEN1): contribution of genetic analysis to the screening and follow-up of a large French kindredC Waterlot, N Porchet, C Bauters, et al.
Diabetes & Metabolism|December 12, 2012
Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotideY Reznik, J Bertherat, F Borson-Chazot, et al.
Annales D'Endocrinologie|May 20, 2008
TSH-secreting adenoma improved with cabergolineF Mouton, F Faivre-Defrance, C Cortet-Rudelli, et al.
European Journal of Endocrinology|March 5, 2014
Patients lost to follow-up in acromegaly: results of the ACROSPECT studyB Delemer, Ph Chanson, L Foubert, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotideJ M Kuhn, S Arlot, H Lefebvre, et al.
European Journal of Endocrinology|December 24, 2016
Cabergoline for Cushing's disease: a large retrospective multicenter studyA Ferriere, C Cortet, P Chanson, et al.
Endocrine-Related Cancer|November 8, 2018
French Endocrine Society Guidance on endocrine side effects of immunotherapyF Castinetti, F Albarel, F Archambeaud, et al.
Clinical Endocrinology|December 7, 2000
Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegalyP Chanson, V Boerlin, C Ajzenberg, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Endocrinology|September 1, 1999
Type 1 multiple endocrine neoplasia (MEN1): contribution of genetic analysis to the screening and follow-up of a large French kindredC Waterlot, N Porchet, C Bauters, et al.
Diabetes & Metabolism|December 12, 2012
Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotideY Reznik, J Bertherat, F Borson-Chazot, et al.
Annales D'Endocrinologie|May 20, 2008
TSH-secreting adenoma improved with cabergolineF Mouton, F Faivre-Defrance, C Cortet-Rudelli, et al.
European Journal of Endocrinology|March 5, 2014
Patients lost to follow-up in acromegaly: results of the ACROSPECT studyB Delemer, Ph Chanson, L Foubert, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotideJ M Kuhn, S Arlot, H Lefebvre, et al.
European Journal of Endocrinology|December 24, 2016
Cabergoline for Cushing's disease: a large retrospective multicenter studyA Ferriere, C Cortet, P Chanson, et al.
Endocrine-Related Cancer|November 8, 2018
French Endocrine Society Guidance on endocrine side effects of immunotherapyF Castinetti, F Albarel, F Archambeaud, et al.
Clinical Endocrinology|December 7, 2000
Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegalyP Chanson, V Boerlin, C Ajzenberg, et al.
Pageof 3